A personalised vaccine against melanoma can more than double the survival
rate for patients with the advanced form of this skin cancer. Doctors at
Jefferson Medical College in Philadelphia create customised vaccines from
patients’ own cancer cells by inactivating them and altering their surface
proteins with dinitrophenol. Five-year survival rates in 214 patients with
advanced disease increased from around 20 per cent to 50 per cent and a
randomised phase III trial of 400 patients across the US is planned.
To continue reading, today with our introductory offers
Advertisement
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
3
How I used psychology to come back from the worst year of my life
4
The distant world that is our best hope of finding alien life
5
Photos reveal unexpected details from the world's first atomic test
6
Epic dreaming is leaving people exhausted and distressed
7
The ‘doomsday’ glacier’s giant ice shelf is about to break away
8
Women’s better memories may delay Alzheimer’s diagnosis by years
9
Mystery of the ancient giant stone jars of Laos may have been solved
10
After news about Oliver Sacks's "lies", we revisit his best-loved book
